NCT02869009View on ClinicalTrials.gov

Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

3,000

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Ischemic Stroke
Interventions
DRUG

clopidogrel

DRUG

Aspirin

Trial Locations (1)

Unknown

General Hospital of Shenyang Military Region, Shenyang

All Listed Sponsors
lead

General Hospital of Shenyang Military Region

OTHER

NCT02869009 - Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke | Biotech Hunter | Biotech Hunter